Lv4
470 积分 2021-02-09 加入
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
18小时前
待确认
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
23小时前
已完结
Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?
23天前
已完结
Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer
1个月前
已完结
Letter to Editor. Re "de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer," Semaglutide a Potential Treatment for Serious Weight Gain From ALK Tyrosine Kinase Inhibitors?
1个月前
已完结
The gut and energy balance: visceral allies in the obesity wars
4个月前
已完结
Pro-inflammatory immune microenvironment and Thrombospondin-1-positive monocytes as drivers of osteoclastogenesis in postmenopausal osteoporosis
6个月前
已完结
Vitamin D3exacerbates steatosis while calcipotriol inhibits inflammation in non-alcoholic fatty liver disease inSod1knockout mice: a comparative study of two forms of vitamin D
7个月前
已完结
The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet
7个月前
已完结
Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery
8个月前
已完结
皖公网安备34019202002308
